Abstract
Therapy with GnRH analogues is the treatment of choice for progressive CPP. Because the improvement of adult height involves only a few centimeters, except in patients who have a very early and robust onset of CPP, therapy generally should not be given in an effort to improve height alone. Therapy is effective in restoring a prepubertal hormonal milieu followed by cessation of pubertal growth and development. Pubertal development, for social and psychologic reasons, can be delayed until a more appropriate age. Progressive CPP can be identified by a clear progression of pubertal changes and an acceleration of growth rates and skeletal maturity, with pubertal hormone levels and responses to GnRH stimulation. A timely institution of therapy would be within a few months of onset once progression can be documented and before height potential is lost. With adequate timing of therapy for progressive CPP, genetically expected adult height can be achieved.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 901-918 |
| Number of pages | 18 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1999 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Fingerprint
Dive into the research topics of 'Central precocious puberty: An overview of diagnosis, treatment, and outcome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver